Ultrasound Assessment of Internal Jugular Vein for Cannulation and Venous Pressure Prediction

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssiut University

About this trial

This prospective observational study aims to evaluate the diagnostic utility of vascular ultrasound for internal jugular vein (IJV) assessment in adult patients undergoing clinically indicated IJV cannulation.

Traditionally, bedside clinical assessment of jugular venous pressure (JVP) is challenging and frequently imprecise in critically ill or obese individuals. This study investigates whether non-invasive ultrasound parameters, specifically IJV diameter, collapsibility index, and Doppler flow patterns, can reliably estimate central venous pressure (CVP) and identify elevated JVP.

Participants admitted to the Intensive Care Unit, Emergency Department, or Operating Theatres who require right IJV catheterization will receive a standardized pre-procedural vascular ultrasound evaluation in a supine position (0-30° head elevation) prior to routine, ultrasound-guided cannulation. Ultrasound measurements will then be compared to direct central venous pressure readings to assess diagnostic accuracy and correlation.

Eligibility criteria

Qualifiers

Adult patients aged 18 years or older.

Patients admitted to the Intensive Care Unit (ICU), Emergency Department, or Operating Theatres who require internal jugular vein (IJV) cannulation for clinical indications.

Patients in whom ultrasound-guided right internal jugular vein cannulation is planned.

Patients who are hemodynamically stable enough to undergo ultrasound examination before cannulation.

Disqualifiers

Patients younger than 18 years of age.

Previous surgery, radiotherapy, or significant trauma involving the neck.

Known thrombosis, stenosis, or congenital anomalies of the internal jugular vein.

Local infection, cellulitis, burn, or hematoma at the intended cannulation site.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

100 Participants
are grouped into 1 trial group

Locations

This trial has no locations

Sponsors and collaborators